Correlation Between Milestone Pharmaceuticals and Jasper Therapeutics
Can any of the company-specific risk be diversified away by investing in both Milestone Pharmaceuticals and Jasper Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Milestone Pharmaceuticals and Jasper Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Milestone Pharmaceuticals and Jasper Therapeutics, you can compare the effects of market volatilities on Milestone Pharmaceuticals and Jasper Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Milestone Pharmaceuticals with a short position of Jasper Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Milestone Pharmaceuticals and Jasper Therapeutics.
Diversification Opportunities for Milestone Pharmaceuticals and Jasper Therapeutics
0.1 | Correlation Coefficient |
Average diversification
The 3 months correlation between Milestone and Jasper is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Pharmaceuticals and Jasper Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Jasper Therapeutics and Milestone Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Milestone Pharmaceuticals are associated (or correlated) with Jasper Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Jasper Therapeutics has no effect on the direction of Milestone Pharmaceuticals i.e., Milestone Pharmaceuticals and Jasper Therapeutics go up and down completely randomly.
Pair Corralation between Milestone Pharmaceuticals and Jasper Therapeutics
Given the investment horizon of 90 days Milestone Pharmaceuticals is expected to under-perform the Jasper Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Milestone Pharmaceuticals is 13.19 times less risky than Jasper Therapeutics. The stock trades about -0.02 of its potential returns per unit of risk. The Jasper Therapeutics is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 12.00 in Jasper Therapeutics on August 31, 2024 and sell it today you would earn a total of 8.00 from holding Jasper Therapeutics or generate 66.67% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 84.49% |
| Values | Daily Returns |
Milestone Pharmaceuticals vs. Jasper Therapeutics
Performance |
| Timeline |
| Milestone Pharmaceuticals |
| Jasper Therapeutics |
Milestone Pharmaceuticals and Jasper Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Milestone Pharmaceuticals and Jasper Therapeutics
The main advantage of trading using opposite Milestone Pharmaceuticals and Jasper Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Milestone Pharmaceuticals position performs unexpectedly, Jasper Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Jasper Therapeutics will offset losses from the drop in Jasper Therapeutics' long position.The idea behind Milestone Pharmaceuticals and Jasper Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Jasper Therapeutics vs. SAB Biotherapeutics | Jasper Therapeutics vs. NRx Pharmaceuticals | Jasper Therapeutics vs. Celularity |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Complementary Tools
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |